Objective: The aim of this study was to explore the mechanism of methyltransferase-like 14 (METTL14) on human endometriotic stromal cell (ESC; HEM15A) proliferation, migration, and invasion to provide novel therapy for endometriosis (EMs). Design: Normal human endometrial stromal cells (HESCs) and HEM15A cells were selected. Corresponding controlled experiments were performed to analyze whether overexpression of METTL14, N6-methyladenosine (m6A) methylated ZEB1 mRNA, upregulation of ZEB1, and activating the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) can affect the proliferation, migration, and invasion of HEM15A cells. Materials, Setting, and Methods: HEM15A and HESCs were cultured in vitro. HEM15A cells were treated with oe-METTL14 and oe-zinc finger E-box-binding protein 1 (ZEB1) plasmids, 3-deazaadenosine (3-DAA) and the MEK/ERK pathway inhibitor isoprenaline (ISO). After identifying HEM15A and HESCs, METTL14, ZEB1, p-ERK1/2/ERK1/2, and p-MEK/MEK levels, and cell proliferation, migration, and invasion were assessed. The modification sites of ZEB1 and m6A were predicted using SRAMP database, with an m6A modification level assessed by MeRIP. The binding of YT521-B homology domain 2 (YTHDF2) to ZEB1 messenger RNA (mRNA), and ZEB1 stability and mRNA level were tested. Results: Compared with HESCs, METTL14 level in HEM15A was significantly reduced. METTL14 overexpression in HEM15A prominently increased its proliferation, migration, and invasion. METTL14 overexpression notably elevated m6A-methylated ZEB1 mRNA level and reduced the stability and expression of ZEB1 mRNA. Further m6A modification inhibition increased ZEB1 mRNA stability and mRNA and protein levels and decreased ZEB1 m6A modification level. ZEB1 upregulation partially reversed METTL14 overexpression-inhibited HEM15A proliferation, migration, and invasion. METTL14 inhibited the MEK/ERK signaling activation by regulating ZEB1, and the MEK/ERK signaling activation partly averted METTL14-suppressed proliferation, migration, and invasion. Limitations: The effects of METTL14 on other growth aspects of HEM15A cells and the relation between ZEB1 and m6A require further investigation. Conclusions: METTL14 lowered ZEB1 expression by regulating ZEB1 m6A modification levels, thereby inhibiting the activation of the MEK/ERK pathway and ESC proliferation, migration, and invasion.

Journal Section:
Research Article
Keywords:
Endometriosis, Methyltransferase-like 14, N6-methyladenosine, Zinc finger E-box-binding protein 1, Mitogen-activated protein kinase kinase/extracellular signal-regulated kinase, YT521-B homology domain 2, Stromal cells, Proliferation, Migration, Invasion
1.
Shi
J
,
Tan
X
,
Feng
G
,
Zhuo
Y
,
Jiang
Z
,
Banda
S
, et al.
Research advances in drug therapy of endometriosis
.
Front Pharmacol
.
2023
;
14
:
1199010
.
Google Scholar
 
2.
Dyson
MT
,
Roqueiro
D
,
Monsivais
D
,
Ercan
CM
,
Pavone
ME
,
Brooks
DC
, et al.
Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis
.
PLoS Genet
.
2014
;
10
(
3
):
e1004158
.
Google Scholar
 
3.
Burney
RO
,
Giudice
LC
.
Pathogenesis and pathophysiology of endometriosis
.
Fertil Steril
.
2012
;
98
(
3
):
511
–
9
.
Google Scholar
 
4.
Chapron
C
,
Marcellin
L
,
Borghese
B
,
Santulli
P
.
Rethinking mechanisms, diagnosis and management of endometriosis
.
Nat Rev Endocrinol
.
2019
;
15
(
11
):
666
–
82
.
Google Scholar
 
5.
Taylor
HS
,
Kotlyar
AM
,
Flores
VA
.
Endometriosis is a chronic systemic disease: clinical challenges and novel innovations
.
Lancet
.
2021
;
397
(
10276
):
839
–
52
.
Google Scholar
 
6.
Sims
OT
,
Gupta
J
,
Missmer
SA
,
Aninye
IO
.
Stigma and endometriosis: a brief overview and recommendations to improve psychosocial well-being and diagnostic delay
.
Int J Environ Res Public Health
.
2021
;
18
(
15
):
8210
.
Google Scholar
 
7.
Hang
Y
,
Tan
L
,
Chen
Q
,
Liu
Q
,
Jin
Y
.
E3 ubiquitin ligase TRIM24 deficiency promotes NLRP3/caspase-1/IL-1β-mediated pyroptosis in endometriosis
.
Cell Biol Int
.
2021
;
45
(
7
):
1561
–
70
.
Google Scholar
 
8.
Moya-Gomez
A
,
Font
LP
,
Burlacu
A
,
Alpizar
YA
,
Cardonne
MM
,
Brone
B
, et al.
Extremely Low-Frequency Electromagnetic Stimulation (ELF-EMS) improves neurological outcome and reduces microglial reactivity in a rodent model of global transient stroke
.
Int J Mol Sci
.
2023
;
24
(
13
):
11117
.
Google Scholar
 
9.
Liu
H
,
Zhang
W
,
Wang
L
,
Zhang
Z
,
Xiong
W
,
Zhang
L
, et al.
GLI1 is increased in ovarian endometriosis and regulates migration, invasion and proliferation of human endometrial stromal cells in endometriosis
.
Ann Transl Med
.
2019
;
7
(
22
):
663
.
Google Scholar
 
10.
Zhang
J
,
Li
H
,
Yi
D
,
Lai
C
,
Wang
H
,
Zou
W
, et al.
Knockdown of vascular cell adhesion molecule 1 impedes transforming growth factor beta 1-mediated proliferation, migration, and invasion of endometriotic cyst stromal cells
.
Reprod Biol Endocrinol
.
2019
;
17
(
1
):
69
.
Google Scholar
 
11.
Wang
X
,
Lu
Z
,
Gomez
A
,
Hon
GC
,
Yue
Y
,
Han
D
, et al.
N6-methyladenosine-dependent regulation of messenger RNA stability
.
Nature
.
2014
;
505
(
7481
):
117
–
20
.
Google Scholar
 
12.
Wang
X
,
Zhao
BS
,
Roundtree
IA
,
Lu
Z
,
Han
D
,
Ma
H
, et al.
N(6)-methyladenosine modulates messenger RNA translation efficiency
.
Cell
.
2015
;
161
(
6
):
1388
–
99
.
Google Scholar
 
13.
Xiao
W
,
Adhikari
S
,
Dahal
U
,
Chen
YS
,
Hao
YJ
,
Sun
BF
, et al.
Nuclear m(6)A reader YTHDC1 regulates mRNA splicing
.
Mol Cell
.
2016
;
61
(
4
):
507
–
19
.
Google Scholar
 
14.
Shi
H
,
Wang
X
,
Lu
Z
,
Zhao
BS
,
Ma
H
,
Hsu
PJ
, et al.
YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA
.
Cell Res
.
2017
;
27
(
3
):
315
–
28
.
Google Scholar
 
15.
Wang
X
,
Wang
J
,
Zhao
X
,
Wu
H
,
Li
J
,
Cheng
Y
, et al.
METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing
.
J Transl Med
.
2023
;
21
(
1
):
407
.
Google Scholar
 
16.
Jiang
L
,
Zhang
M
,
Wu
J
,
Wang
S
,
Yang
X
,
Yi
M
, et al.
Exploring diagnostic m6A regulators in endometriosis
.
Aging
.
2020
;
12
(
24
):
25916
–
38
.
Google Scholar
 
17.
Chen
J
,
Fang
Y
,
Xu
Y
,
Sun
H
.
Role of m6A modification in female infertility and reproductive system diseases
.
Int J Biol Sci
.
2022
;
18
(
9
):
3592
–
604
.
Google Scholar
 
18.
Fu
Y
,
Dominissini
D
,
Rechavi
G
,
He
C
.
Gene expression regulation mediated through reversible m6A RNA methylation
.
Nat Rev Genet
.
2014
;
15
(
5
):
293
–
306
.
Google Scholar
 
19.
Shen
L
,
Zhang
C
,
Zhang
Y
,
Yang
Y
.
METTL3 and METTL14-mediated N(6)-methyladenosine modification promotes cell proliferation and invasion in a model of endometriosis
.
Reprod Biomed Online
.
2023
;
46
(
2
):
255
–
65
.
Google Scholar
 
20.
Zhang
Y
,
Liu
X
,
Liang
W
,
Dean
DC
,
Zhang
L
,
Liu
Y
.
Expression and function of ZEB1 in the cornea
.
Cells
.
2021
;
10
(
4
):
925
.
Google Scholar
 
21.
Konrad
L
,
Gronbach
J
,
Horne
F
,
Mecha
EO
,
Berkes
E
,
Frank
M
, et al.
Similar characteristics of endometrial and endometriotic epithelial cells
.
Reprod Sci
.
2019
;
26
(
1
):
49
–
59
.
Google Scholar
 
22.
Liu
Y
,
Lu
C
,
Fan
L
,
Wang
J
,
Li
T
,
Liu
Z
, et al.
MiR-199a-5p targets ZEB1 to inhibit the epithelial-mesenchymal transition of ovarian ectopic endometrial stromal cells via PI3K/Akt/mTOR signal pathway in vitro and in vivo
.
Reprod Sci
.
2020
;
27
(
1
):
110
–
8
.
Google Scholar
 
23.
Eggers
JC
,
Martino
V
,
Reinbold
R
,
Schafer
SD
,
Kiesel
L
,
Starzinski-Powitz
A
, et al.
microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4
.
Reprod Biomed Online
.
2016
;
32
(
4
):
434
–
45
.
Google Scholar
 
24.
Ou
B
,
Liu
Y
,
Gao
Z
,
Xu
J
,
Yan
Y
,
Li
Y
, et al.
Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation
.
Cell Death Dis
.
2022
;
13
(
10
):
905
.
Google Scholar
 
25.
Zhou
X
,
Zhu
A
,
Gu
X
,
Xie
G
.
Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation
.
Cell Oncol
.
2019
;
42
(
3
):
369
–
80
.
Google Scholar
 
26.
Barbosa
R
,
Acevedo
LA
,
Marmorstein
R
.
The MEK/ERK network as a therapeutic target in human cancer
.
Mol Cancer Res
.
2021
;
19
(
3
):
361
–
74
.
Google Scholar
 
27.
Zhang
D
,
Wang
L
,
Guo
HL
,
Zhang
ZW
,
Wang
C
,
Chian
RC
, et al.
MicroRNA-202 inhibits endometrial stromal cell migration and invasion by suppressing the K-Ras/Raf1/MEK/ERK signaling pathway
.
Int J Mol Med
.
2020
;
46
(
6
):
2078
–
88
.
Google Scholar
 
28.
Zhou
M
,
Fu
J
,
Xiao
L
,
Yang
S
,
Song
Y
,
Zhang
X
, et al.
miR-196a overexpression activates the MEK/ERK signal and represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis
.
Hum Reprod
.
2016
;
31
(
11
):
2598
–
608
.
Google Scholar
 
29.
Gurbuz
N
,
Kahraman
N
,
Sonmez
HE
,
Mokhlis
HA
,
Kosar
PA
,
Ozpolat
B
.
miRNA-193b-5p suppresses pancreatic cancer cell proliferation, invasion, epithelial mesenchymal transition, and tumor growth by inhibiting eEF2K
.
Anticancer Agents Med Chem
.
2022
;
22
(
14
):
2607
–
18
.
Google Scholar
 
30.
Chen
Q
,
Hang
Y
,
Zhang
T
,
Tan
L
,
Li
S
,
Jin
Y
.
USP10 promotes proliferation and migration and inhibits apoptosis of endometrial stromal cells in endometriosis through activating the Raf-1/MEK/ERK pathway
.
Am J Physiol Cell Physiol
.
2018
;
315
(
6
):
C863
–
72
.
Google Scholar
 
31.
Yu
PL
,
Wu
R
,
Cao
SJ
,
Wen
YP
,
Huang
XB
,
Zhao
S
, et al.
Pseudorabies virus exploits N(6)-methyladenosine modification to promote viral replication
.
Front Microbiol
.
2023
;
14
:
1087484
.
Google Scholar
 
32.
Li
R
,
Qi
Y
,
Yuan
Q
,
Xu
L
,
Gao
M
,
Xu
Y
, et al.
Protective effects of dioscin against isoproterenol-induced cardiac hypertrophy via adjusting PKCε/ERK-mediated oxidative stress
.
Eur J Pharmacol
.
2021
;
907
:
174277
.
Google Scholar
 
33.
Kralickova
M
,
Losan
P
,
Vetvicka
V
.
Endometriosis and cancer
.
Womens Health (Lond)
.
2014
;
10
(
6
):
591
–
7
.
Google Scholar
 
34.
Zhang
BY
,
Han
L
,
Tang
YF
,
Zhang
GX
,
Fan
XL
,
Zhang
JJ
, et al.
METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion
.
Eur Rev Med Pharmacol Sci
.
2020
;
24
(
12
):
7015
–
23
.
Google Scholar
 
35.
Zhao
Y
,
Hu
J
,
Sun
X
,
Yang
K
,
Yang
L
,
Kong
L
, et al.
Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A
.
Clin Transl Med
.
2021
;
11
(
5
):
e402
.
Google Scholar
 
36.
Fang
Z
,
Mei
W
,
Qu
C
,
Lu
J
,
Shang
L
,
Cao
F
, et al.
Role of m6A writers, erasers and readers in cancer
.
Exp Hematol Oncol
.
2022
;
11
(
1
):
45
.
Google Scholar
 
37.
Liu
P
,
Li
F
,
Lin
J
,
Fukumoto
T
,
Nacarelli
T
,
Hao
X
, et al.
m(6)A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype
.
Nat Cell Biol
.
2021
;
23
(
4
):
355
–
65
.
Google Scholar
 
38.
Fan
W
,
Zhou
W
,
Yan
Q
,
Peng
Y
,
Wang
H
,
Kong
C
, et al.
Upregulation of METTL14 contributes to trophoblast dysfunction by elevating FOXO3a expression in an m(6)A-dependent manner
.
Placenta
.
2022
;
124
:
18
–
27
.
Google Scholar
 
39.
Li
X
,
Xiong
W
,
Long
X
,
Dai
X
,
Peng
Y
,
Xu
Y
, et al.
Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis†
.
Biol Reprod
.
2021
;
105
(
5
):
1221
–
33
.
Google Scholar
 
40.
Wu
RF
,
Chen
ZX
,
Zhou
WD
,
Li
YZ
,
Huang
ZX
,
Lin
DC
, et al.
High expression of ZEB1 in endometriosis and its role in 17β-estradiol-induced epithelial-mesenchymal transition
.
Int J Clin Exp Pathol
.
2018
;
11
(
10
):
4744
–
58
.
Google Scholar
 
41.
Furuya
M
,
Masuda
H
,
Hara
K
,
Uchida
H
,
Sato
K
,
Sato
S
, et al.
ZEB1 expression is a potential indicator of invasive endometriosis
.
Acta Obstet Gynecol Scand
.
2017
;
96
(
9
):
1128
–
35
.
Google Scholar
 
42.
Gu
Y
,
Zhao
Y
,
Zhou
Y
,
Xie
Y
,
Ju
P
,
Long
Y
, et al.
Zeb1 is a potential regulator of Six2 in the proliferation, apoptosis and migration of metanephric mesenchyme cells
.
Int J Mol Sci
.
2016
;
17
(
8
):
1283
.
Google Scholar
 
43.
Hung
SW
,
Zhang
R
,
Tan
Z
,
Chung
JPW
,
Zhang
T
,
Wang
CC
.
Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: a review
.
Med Res Rev
.
2021
;
41
(
4
):
2489
–
564
.
Google Scholar
 
44.
Zheng
Y
,
Zhang
Z
,
Zheng
D
,
Yi
P
,
Wang
S
.
METTL14 promotes the development of diabetic kidney disease by regulating m(6)A modification of TUG1
.
Acta Diabetol
.
2023
;
60
(
11
):
1567
–
80
.
Google Scholar
 
45.
Singh
VJ
,
Sharma
B
,
Chawla
PA
.
Recent developments in mitogen activated protein kinase inhibitors as potential anticancer agents
.
Bioorg Chem
.
2021
;
114
:
105161
.
Google Scholar
 
46.
Wu
PK
,
Becker
A
,
Park
JI
.
Growth inhibitory signaling of the raf/MEK/ERK pathway
.
Int J Mol Sci
.
2020
;
21
(
15
):
5436
.
Google Scholar
 
47.
Wang
F
,
Li
YM
,
Li
RY
,
Yang
YE
,
Wei
M
,
Ha
C
.
U0126 and BAY11-7082 inhibit the progression of endometriosis in a rat model by suppressing the MEK/ERK/NF-κB pathway
.
Womens Health Rep
.
2023
;
4
(
1
):
65
–
77
.
Google Scholar
 
© 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.